Else Nutrition Outpacing Category/Competitive Growth Benchmarks on Amazon U.S.

4395 logoo20Else20Nutrition 2

-Last 6 months on platform: Else growth rate exceeds that of competitive brands in same category.

-62% Repeat Purchase rate on the platform, exceeds same category brands’ rate by double-digits.

 

amazo

 

VANCOUVER, BC, October 27, 2021 – ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) (“Else” or the “Company”) the Plant-Based baby, toddler and children nutrition company is pleased to announce strong performance results on the Amazon platform. According to recent Amazon data, Else Nutrition sales have grown by an average of approximately 10% month-over-month over the last 6 months; outpacing growth by brands in the same category to Else, each month.

Further indicators of the Company’s performance on the world’s largest E-commerce marketplace:

 

  • 62% repurchase rate, compared to 40-45% repurchase rate for brands in same category.
  • 16% of purchasers have procured the product at least 10 times or more.
  • Subscriptions on the platform have grown rapidly and continue to grow.

 

“We’re very encouraged by these results,” said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. “This robust growth and high repurchase rate are showing that there’s a strong and loyal base of customers for our clean whole foods-based products.

 

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board  members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies,  and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

 

Media Contact

Callie Rapp
Brilliant PR
callier@brilliantpr.com

 

For more information, contact:

Mrs. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: hamutaly@elsenutrition.com
P: +972(0)3-6445095
Mr. Sokhie Puar, Director of Else Nutrition
E:  sokhiep@elsenutrition.com
P:  604-603-7787

 

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents.  Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate.  Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.  Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

iCrowdNewswire